Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis
- Author(s)
- Yuan, Z; van Delft, MF; Li, MX; Sumardy, F; Smith, BJ; Huang, DCS; Lessene, G; Khakam, Y; Jin, R; He, S; Smith, NA; Birkinshaw, RW; Czabotar, PE; Dewson, G;
- Details
- Publication Year 2024-05-02,Volume 22,Issue #5,Page e3002617
- Journal Title
- PloS Biology
- Publication Type
- Research article
- Abstract
- BAK and BAX execute intrinsic apoptosis by permeabilising the mitochondrial outer membrane. Their activity is regulated through interactions with pro-survival BCL-2 family proteins and with non-BCL-2 proteins including the mitochondrial porin VDAC2. VDAC2 is important for bringing both BAK and BAX to mitochondria where they execute their apoptotic function. Despite this important function in apoptosis, while interactions with pro-survival family members are well characterised and have culminated in the development of drugs that target these interfaces to induce cancer cell apoptosis, the interaction between BAK and VDAC2 remains largely undefined. Deep scanning mutagenesis coupled with cysteine linkage identified key residues in the interaction between BAK and VDAC2. Obstructive labelling of specific residues in the BH3 domain or hydrophobic groove of BAK disrupted this interaction. Conversely, mutating specific residues in a cytosol-exposed region of VDAC2 stabilised the interaction with BAK and inhibited BAK apoptotic activity. Thus, this VDAC2-BAK interaction site can potentially be targeted to either inhibit BAK-mediated apoptosis in scenarios where excessive apoptosis contributes to disease or to promote BAK-mediated apoptosis for cancer therapy.
- Publisher
- PLOS
- Department(s)
- Laboratory Research
- Publisher's Version
- https://doi.org/10.1371/journal.pbio.3002617
- Open Access at Publisher's Site
https://doi.org/10.1371/journal.pbio.3002617- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-07-25 05:42:29
Last Modified: 2024-07-25 05:52:23